Automated real-world data integration improves cancer outcome prediction
2024 · Nature · 123 citations
https://doi.org/10.1038/s41586-024-08167-5
H
Henry Walch
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
422
Papers
2.2K
Citations
21
h-index
30
i10-index
Henry Walch is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Esophageal Cancer Research and Treatment & Lung Cancer Treatments and Mutations. The author has an h-index of 21, co-authored 359 publications.
ORCID: 0000-0003-1188-350XPapers by this author
worksClinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
2023 · JNCI Journal of the National Cancer Institute · 28 citations
https://doi.org/10.1093/jnci/djad186
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
2023 · Clinical Cancer Research · 25 citations
https://doi.org/10.1158/1078-0432.ccr-22-3769
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer
2024 · Clinical Cancer Research · 7 citations
https://doi.org/10.1158/1078-0432.ccr-23-4005
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy
2024 · JNCI Journal of the National Cancer Institute · 5 citations
https://doi.org/10.1093/jnci/djae202
Clinical and Genomic Characterization of <i>ERBB2</i> -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort
2024 · JCO Global Oncology · 3 citations
https://doi.org/10.1200/go.24.00090
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat